Increased CD44 expression has been reported in neuroinflammatory conditions [46,47], and its dysregulation may exacerbate microglial activation and glutamate excitotoxicity, both of which have been implicated in MDD [48–50]. The gene discussed is CD44; the disease is major depressive disorder.